In short
Hashimoto's thyroiditis is an autoimmune condition in which the immune system produces antibodies against thyroid tissue, progressively destroying thyroid function and producing hypothyroidism. At CLCC, care for hashimoto's thyroiditis follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.
About This Condition
Hashimoto's is an autoimmune condition that expresses through the thyroid, the immune system is the problem.
Hashimoto's thyroiditis is an autoimmune condition in which the immune system produces antibodies against thyroid tissue, progressively destroying thyroid function and producing hypothyroidism. It is the most common cause of underactive thyroid globally. Standard management is thyroid hormone replacement, thyroxine, which replaces the hormone the damaged thyroid can no longer produce adequately. This is appropriate and necessary. But it does not address the immune attack that is continuing to damage thyroid tissue.
The drivers of Hashimoto's immune dysregulation are systemic, not thyroid-specific. Gut barrier dysfunction allows thyroid-mimicking bacterial antigens into the bloodstream, triggering cross-reactive antibody production that attacks thyroid tissue. Selenium and vitamin D deficiency directly impair the immune regulatory mechanisms that would otherwise suppress anti-thyroid antibody production. Gluten sensitivity, even without coeliac disease, is documented in a significant proportion of Hashimoto's patients. CLCC addresses these systemic drivers to reduce the immune attack on the thyroid, which helps reduce TPO antibody levels and may slow or halt progressive thyroid destruction.
Symptoms
Common symptoms and presentations.
Fatigue, often profound, not fully relieved by adequate thyroid hormone replacement
Weight gain or difficulty losing weight despite normal TSH
Cold intolerance, feeling cold when others are comfortable
Brain fog and cognitive slowness
Constipation and slow gut motility
Elevated TPO and/or anti-thyroglobulin antibodies on blood testing
Symptoms persisting despite apparently adequate thyroxine dose
Contributing Factors
What drives and sustains this condition.
Gut barrier dysfunction
Increased gut permeability allows bacterial antigens that cross-react with thyroid tissue into the bloodstream, triggering anti-thyroid antibody production. Gut barrier repair helps reduce TPO antibody levels.
Selenium deficiency
Selenium is essential for thyroid hormone conversion (T4 to T3) and for the glutathione peroxidase enzyme that protects thyroid tissue from oxidative damage. Selenium deficiency directly impairs both thyroid function and immune regulation in Hashimoto's.
Vitamin D deficiency
Vitamin D suppresses the Th1 immune response that produces anti-thyroid antibodies. Vitamin D deficiency is significantly more prevalent in Hashimoto's patients than in controls. Therapeutic correction helps reduce TPO antibody levels.
Gluten sensitivity
Non-coeliac gluten sensitivity is documented in a significant proportion of Hashimoto's patients, driven by molecular mimicry between gliadin peptides and thyroid tissue. Gluten elimination reduces antibody levels in a subset of patients with this sensitivity pattern.
The CLCC Method: All Five Steps
Assessment first. Then all five steps, applied specifically.
Assess gut health, nutritional status, and full thyroid antibody profile
TPO and anti-thyroglobulin antibodies reviewed alongside TSH, free T3, free T4. Gut barrier integrity and microbiome indicators assessed. Selenium, vitamin D, and zinc levels evaluated. Gluten sensitivity investigated through dietary history and relevant markers.
Identify dominant drivers, gut, selenium/vitamin D deficiency, gluten, or stress
The relative contribution of each determines care plan priority. Some patients have a predominantly gut-driven pattern. Others have severe selenium deficiency as the dominant factor. Gluten sensitivity requires dietary investigation as a distinct pathway.
Gut barrier repair, selenium, vitamin D, and targeted dietary correction
Gut barrier repair protocol. Therapeutic selenium supplementation with monitoring. Vitamin D3 correction to optimal levels. Gluten elimination trial where sensitivity is indicated. Anti-inflammatory dietary protocol.
Track TPO antibody levels and thyroid function at defined intervals
TPO and anti-thyroglobulin antibodies tracked alongside TSH, free T3, and T4 at structured intervals. Antibody reduction is the measurable marker of immune regulation improvement. Thyroid hormone dosage review in coordination with prescribing physician.
Long-term autoimmune thyroid management
Hashimoto's requires indefinite monitoring. The Continue phase maintains the gut health and nutritional environment that supports reduced anti-thyroid antibody production, monitoring thyroid function annually and adjusting nutritional support as needed.
FAQs
Common questions about care.
If my TSH is normal on thyroxine, why do I still feel unwell?+
Normal TSH on thyroxine replacement means thyroid hormone levels are being pharmacologically maintained, but it does not mean the immune attack on thyroid tissue has stopped or that T3 conversion is optimal. Many Hashimoto's patients with normal TSH have suboptimal free T3, ongoing antibody production, and symptoms driven by the continuing autoimmune activity. CLCC addresses these dimensions.
Does a gluten-free diet help Hashimoto's?+
For patients with Hashimoto's and gluten sensitivity, not necessarily coeliac disease, gluten elimination helps reduce TPO antibody levels and improves symptom burden. Not all Hashimoto's patients have this sensitivity. The CLCC assessment investigates the specific pattern to determine whether gluten elimination is a priority intervention for each patient.